Join Us at the 2025 Autumn International Beauty & Cosmetics Show

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With our patented Bio-Pulsed Exosome ExoGiov®, we have been recognized by leading international cosmetic brands as one of the Top Five Innovative Ingredients Worldwide.

At this exhibition, held from September 26–29, 2025 at Taipei World Trade Center Hall 1, Booth A1109, we will be showcasing our latest skincare and haircare innovations, as well as cutting-edge application services.

We warmly welcome brand owners and OEM/ODM partners to visit us and explore opportunities for collaboration. At the same time, we sincerely invite research institutes and medical institutions to join us in R&D partnerships, CDMO manufacturing, and the advancement of pre-clinical and clinical studies, accelerating the path of innovative technologies into the market.

📍 Venue: Taipei World Trade Center Hall 1 (No. 5, Section 5, Xinyi Road, Xinyi District, Taipei City, Taiwan)
📆 Date: September 26–29, 2025
👉 Ascension Medical Biotechnology – Booth A1109

We sincerely look forward to your visit and to exploring together the limitless possibilities of Bio-Pulsed Exosomes!

更多文章read more

Join Us at the 2025 Autumn International Beauty & Cosmetics Show

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With our patented Bio-Pulsed Exosome ExoGiov®, we have been recognized by leading international cosmetic brands as one of the Top Five Innovative Ingredients Worldwide.

Advancing into the ASEAN Market: AM BioTech Enters Malaysia-Taiwan Great Health Exhibition Centre

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation

Join Us at Asia Beauty & Healthcare Show 2025

AM Biotech is excited to unveil two groundbreaking themes at this year's "Asia Beauty & Healthcare Show" (part of the Asia Biotech Exhibition series): Cosmetic Hair Growth and CDMO (Targeting Various Diseases).

ExoGiov® Innovation: AM Biotech Accelerates European Expansion

ExoGiov®, a cosmetic raw material developed by AM Biotech, is registered under the international INCI name: "Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles."

AM Biotech Wins Prestigious 「National Innovation Award」, Leading the Way in Bio-Pulsed Exosome Research

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.

AM Bio Tech Unveils ” Patented Bio-Pulsed Technology ” at Forum

AM Bio Tech's "Patented Bio-Pulsed Technology Forum" held on December 15, 2024, successfully concluded. The event delved deep into the groundbreaking innovation behind Patented Bio-Pulsed Technology, shedding light on its mechanisms and providing compelling evidence of its effectiveness in skin rejuvenation and hair restoration. The

With outstanding R&D achievements and impressive revenue performance, Ascension Medical Biotechnology (AM BioTech) has formed a partnership with the Medical and Pharmaceutical Industry Technology and Development Center (PITDC) to launch multiple biotech projects and enter the trillion-dollar pharmaceutical market

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a

【Exhibition Preview】July 25-28, AM Biotech to Showcase Innovative Technologies, Ingredients, and New Products at the Asia Healthcare & Medical Cosmetology Expo 2024

Biotechnology ✕ Beauty and Health "Asia Healthcare & Medical Cosmetology Expo 2024" showcases projects covering biotech pharmaceuticals, medicine, beauty care, and health. This year, AM Biotech is also participating, presenting our exclusive "Bio-Pulsed" patented technology, scientifically backed beauty and hair care ingredient ExoGiov® Bio-Pulsed Exosomes,

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing